Global Antifibrinolytic Drugs Market Share, Segmentation, Analysis & Trends 2024-2032 | IMARC Group
The latest report by IMARC Group, titled “ Antifibrinolytic Drugs Market Report by Indication (Gynecology, Hereditary Angioedema, Fibrinolytic Response Testing, Surgeries, and Others), Form (Oral, Injectable), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Trauma Centers, and Others), and Region 2024-2032 ”, offers a comprehensive analysis of the industry, which comprises insights on the market. The global antifibrinolytic drugs market size reached US$ 16.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 24.2 Billion by 2032, exhibiting a growth rate (CAGR) of 3.97% during 2024-2032. Influential Factors Influencing the Growth of the Antifibrinolytic Drugs Industry: Rising Number of Surgeries: The increasing demand for antifibrinolytic drugs is closely tied to the growing number of surgical procedures worldwide, particularly in cardiac, orthopedic, liver, and trauma surgeries. As the population ages and the prevalence of conditions requiring...